Metformin Causes G1-Phase Arrest via Down-Regulation of MiR-221 and Enhances TRAIL Sensitivity through DR5 Up-Regulation in Pancreatic Cancer Cells. [electronic resource]
Producer: 20160202Description: e0125779 p. digitalISSN:- 1932-6203
- Antineoplastic Agents -- toxicity
- Apoptosis -- drug effects
- Apoptosis Regulatory Proteins -- metabolism
- Bcl-2-Like Protein 11
- Cell Line, Tumor
- Cell Proliferation -- drug effects
- Cyclin-Dependent Kinase Inhibitor p27 -- metabolism
- Down-Regulation -- drug effects
- Drug Resistance, Neoplasm -- drug effects
- G1 Phase Cell Cycle Checkpoints -- drug effects
- Humans
- Membrane Proteins -- metabolism
- Metformin -- toxicity
- MicroRNAs -- antagonists & inhibitors
- Oligonucleotides, Antisense -- metabolism
- Pancreatic Neoplasms -- metabolism
- Proto-Oncogene Proteins -- metabolism
- Receptors, TNF-Related Apoptosis-Inducing Ligand -- metabolism
- TNF-Related Apoptosis-Inducing Ligand -- toxicity
- Tumor Suppressor Protein p53 -- genetics
- Up-Regulation -- drug effects
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.